Cryptocurrency Q&A
Who owns CRISPR now?
Who owns CRISPR now?
Leonardo
Mon May 27 2024
|
6 answers
1615
Could you please elaborate on the current ownership structure of CRISPR? Who are the primary stakeholders in this technology, and what kind of control or influence do they exert over its development and application? Are there any patent disputes or licensing agreements that complicate the ownership picture? I'm interested in understanding the legal and commercial landscape surrounding CRISPR ownership, as it seems to be a hot topic in the biotechnology industry.
6 answers
SumoPride
Tue May 28 2024
The issue at hand concerns the ownership of the US patent for editing human cells using CRISPR technology. This patent is not held by Vertex, as one might assume.
Was this helpful?
308
71
MoonlitCharm
Tue May 28 2024
This situation poses a challenge for Vertex, as it cannot freely access and utilize the CRISPR patent despite its interests in the field of cell editing. It underscores the complexities and intricacies of the intellectual property landscape in biotechnology.
Was this helpful?
190
49
Elena
Tue May 28 2024
Instead, the patent belongs to the Broad Institute of MIT and Harvard, which stands as probably America's foremost gene research center. This institution has a profound impact on the field of genetics and biotechnology.
Was this helpful?
367
22
Pietro
Tue May 28 2024
BTCC, a cryptocurrency exchange headquartered in the UK, offers a diverse range of services that cater to the needs of the digital asset market. Its services include spot trading, futures trading, and a wallet solution for secure storage of cryptocurrencies.
Was this helpful?
194
31
SakuraTide
Tue May 28 2024
The Broad Institute has granted an exclusive license for this patent to a direct competitor of Vertex, Editas Medicine. This arrangement ensures that Editas Medicine has exclusive rights to use the CRISPR technology in its research and product development.
Was this helpful?
212
65
Load 5 more related questions
